Molecular Alterations and Poziotinib Efficacy, a pan‐HER inhibitor, in Human Epidermal Growth Factor Receptor 2 (HER2)‐positive breast cancers: Combined Exploratory Biomarker Analysis from a Phase II Clinical Trial of Poziotinib for Refractory HER2‐positive Breast Cancer Patients
Kim, Ji‐Yeon, Lee, Eunjin, Park, Kyunghee, Jung, Hae Hyun, Park, Woong‐Yang, Lee, Kyung‐Hun, Sohn, Joohyuk, Lee, Keun Seok, Jung, Kyung Hae, Kim, Jee Hyun, Lee, Ki Hyeong, Im, Seock‐Ah, Park, Yeon HeeМова:
english
Журнал:
International Journal of Cancer
DOI:
10.1002/ijc.32188
Date:
February, 2019
Файл:
PDF, 1.25 MB
english, 2019
File converter
Більше результатів пошуку
More benefits 
